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	 Summary
Objective: The aim of the study was to evaluate the potential risk factors for adenomyosis in patients with 
symptomatic uterine leiomyomas. 
Material and methods: The medical charts and histopathology reports of 1499 women who underwent 
hysterectomy between 2003-2007 were retrospectively reviewed. The study group was composed of 135 patients 
with coexisting uterine leiomyoma and adenomyosis. The control group comprised 176 patients with uterine 
leiomyoma without adenomyosis. 
Results: Among 233 patients with adenomyosis 135 (57.9%) had associated uterine fibroids. Women who 
delivered twice or more were at increased risk for adenomyosis in relation to nulliparuos women: RR (95% CI) 2.44 
(1.04-5.72), p=0.040. No relationship was found between adenomyosis and cesarean section rate, abortions, 
menorrhagia or dysmenorrhea. 
Conclusion: Results of our study indicate that multiparity is a risk factor for adenomyosis in women with 
symptomatic leiomyomas. 
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	 Streszczenie
Cel pracy: Celem badania była ocena potencjalnych czynników ryzyka występowania adenomiozy u pacjentek 
operowanych z powodu mięśniaków macicy. 
Materiał i metody: Retrospektywnej analizie poddano historie chorób oraz wyniki pooperacyjnych badań 
histopatologicznych 1499 pacjentek, u których wykonano histerektomię w latach 2003-2007. Badana grupa 
obejmowała 135 pacjentki, u których zdiagnozowano mięśniaki macicy oraz adenomiozę. Do grupy kontrolnej 
zakwalifikowywano pacjentki z rozpoznaną mięśniakowatością macicy, bez adenomiozy. 
Wyniki: Wśród 233 pacjentek ze zdiagnozowaną adenomiozą, u 135 (57,9%) zdiagnozowano mięśniaki macicy. 
Kobiety rodzące dwa bądź więcej razy były w grupie zwiększonego ryzyka występowania adenomiozy w porównaniu 
z nieródkami: RR (95% CI) 2.44 (1,04-5,72), p=0,040. Nie wykazano zależności pomiędzy występowaniem 
adenomiozy i ilością cięć cesarskich, poronieniami, nieprawidłowymi krwawieniami i bolesnym miesiączkowaniem. 
Wnioski: Wyniki naszego badania wskazują, że wielorództwo u kobiet z mięśniakami macicy jest czynnikiem 
ryzyka występowania adenomiozy.
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Introduction
Adenomyosis	 is	a	benign	condition	defined	as	a	growth	of	
the	endometrial	glands	and	stroma	deep	into	the	myometrium	[1].	
Despite	its	high	prevalence,	etiology	of	adenomyosis	has	been	not	
completely	explained.	Epidemiological	data	indicate	that	parity,	
caesarean	section,	induced	abortion,	dilatation	and	curettage,	use	
of	tamoxifen,	uterine	malformation	and	late	age	at	menarche	may	
be	 the	 risk	 factors	 for	adenomyosis	development	 [2,	3,	4,	5,	6,	
7,	8].	
However,	due	to	the	fact	that	adenomyosis	is	rarely	diagnosed	
prior	 to	 hysterectomy	 and	 usually	 concurs	 with	 other	 pelvic	
pathologies,	 a	 significant	 selection	 bias	 in	 studied	 populations	
makes	 results	 of	 epidemiological	 studies	 contradictory.	 Most	
frequently	adenomyosis	coexist	with	leiomyomas.	It	is	diagnosed	
in	 approximately	 20%	 of	 uterine	 specimens	 removed	 due	 to	
fibroids	and	35-55%	of	all	cases	of	adnomyosis	is	found	together	
with	leiomyomas	[3,	4,	5,	8].	
Preoperative	 identification	of	adenomyosis	coexisting	with	
fibroids	 is	difficult,	however	 it	may	be	of	great	 importance	 for	
patients	scheduled	for	uterine	artery	embolisation,	as	presence	of	
adenomyosis	may	be	the	reason	for	failure	of	the	procedure	[9].
The	 aim	 of	 this	 study	 was	 to	 evaluate	 the	 potential	 risk	
factors	 for	 adenomyosis	 in	 patients	 with	 symptomatic	 uterine	
leiomyomas.	
Material	and	methods
This retrospective	 study	 comprised	 1499	 women	 who	
underwent	 hysterectomy	 at	 2nd	 Department	 of	 Gynecology	
Medical	University	of	Lublin,	Poland	between	2003-2007.	
The	 patients’	 charts	 and	 histopathology	 reports	 were	
systematically	reviewed	and	demographic,	obstetric	and	clinical	
data	were	obtained.	
Adenomyosis	was	diagnosed	when	the	distance	between	the	
lower	 border	 of	 the	 endometrium	 and	 the	 affected	myometrial	
area	was	2.5mm	or	more.	The	study	group	included	135	patients	
with	coexisting	uterine	leiomyoma	and	adenomyosis.	The	control	
group	 comprised	 176	 patients	with	 uterine	 leiomyoma	without	
adenomyosis.	 First	 fifty	 consecutive	 hysterectomies	 from	 each	
year	were	selected	and	patients	with	uterine	leiomyomas	qualified	
for	the	control	group.		
Statistical	 analysis	 was	 performed	 with	 StatisticaStatsoft	
vrs	8	software	((Statsoft	Inc,.	Tulusa,	OK,	USA)).	T-test,	χ2,	and	
logistic	regression	analysis	were	used	as	appropriate.	A	p	value	
less	than	0.05	was	considered	statistically	significant.	
Results	
Adenomyosis	was	diagnosed	in	233	(15.5%)	patients.	One	
hundred	and	thirty-five	of	 them	(57.9%)	had	associated	uterine	
fibroids.	Indications	for	surgery	in	other	patients	with	adenomyosis	
were:	uterine	prolapse,	metrorrhagia,	cervical	carcinoma,	benign	
ovarian	 tumour,	 ovarian	 carcinoma,	 endometrial	 hyperplasia	
with	atypia		and	endometrial	carcinoma.	Adenomyosis	has	been	
suspected	prior	to	surgery	only	in	4	cases	(1.73	%).	
Patients	 from	 study	 and	 control	 groups	 did	 not	 differ	
significantly	in	terms	of	age,	BMI	and	parity.	(Table	I).
Multiparity	appeared	to	be	the	only	risk	factor	associated	with	
presence	 of	 adenomyosis.	 No	 relationship	 was	 found	 between	
adenomyosis	and	cesarean	 section	 rate,	 abortions,	menorrhagia	
or	dysmenorrhea.	(Table	I).	
Comment
Despite	 prevalent	 coexistence	 of	 leiomyomas	 and	
adenomyosis,	 it	 is	 rather	 unlikely	 that	 these	 conditions	 share	
common	 pathogenetic	 features.	 Although	 both	 are	 estrogen	
dependent,	gene	expression	profile	differs	significantly	between	
leiomyomas	and	adenomyosis	[10].	
Table I. Univariate analysis of risk factors for adenomyosis in women with symptomatic uterine leiomoymas.  
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Risk	 factors	 for	 development	 of	 both	 diseases	 seem	 to	 be	
different	as	well.	Risk	of	leiomyomas	is	up	to	four	time	higher	in	
nulliparous	than	in	multiparous	women	[11],	whereas	development	
of	 adenomyosis	 is	 attributed	 to	 such	 reproductive	 factors	 as	
multiparity,	cesarean	section	or	 induced	abortion	 [3,	4,	5,	6,	7,	
8].	Most	 probably,	 the	 fact	 that	 both	 disorders	 are	widespread	
and	 that	 uterine	 leiomyomas	 are	 the	 most	 frequent	 indication	
for	 hysterectomy	may	 account	 for	 high	 rate	 of	 coincidence	 in	
posthysterectomy	specimens.
In	 this	 study	 we	 evaluated	 obstetric	 and	 clinical	 factors	
potentially	 influencing	 the	presence	of	adenomyosis	 in	patients	
hysterectomized	 due	 to	 symptomatic	 uterine	 lyiomomas.	
Multiparity	appeared	to	be	the	only	significant	factor	increasing	
the	incidence	of	adenomyosis.	Relative	risk	of	adenomyosis	was	
more	than	twice	higher	in	multiparous	compared	with	nulliparous	
women.	Other	reproductive	factors	such	as	spontaneous	abortion	
and	 cesarean	 section	 had	 no	 significant	 effect.	 Association	
between	multiparity	and	adenomyosis	has	been	recognized	earlier	
for	the	populations	of	hysterectomized	women	regardless	of	the	
indications	for	surgery	[1].	
Our	study	showed	that	birth	trauma	may	also	play	important	
pathogenectic	 role	 in	 development	 of	 adenomyosis	 in	 patients	
who	underwent	surgery	due	to	fibroids.	Role	of	cesarean	section	
is	 less	 clear.	 Some	 reports	 indicated	 that	 abdominal	 delivery	
increases	the	rate	of	adenomyosis	[2,	4,	12],	but	other,	in	line	with	
our	findings,	did	not	find	such	association	[3,	7,	8,	13].	
Diagnosis	of	adenomyosis	may	be	of	great	 importance	 for	
patients	 with	 symptomatic	 leiomyomas	 selected	 for	 uterine-
sparing	procedures	 such	as	uterine	 artery	 embolization	 (UAE).	
Smith	 et	 al.	 [9]	 showed	 that	 patients	 after	 UAE	 who	 were	
scheduled	for	hysterectomy	due	to	persistent	abnormal	bleeding	
and	pelvic	pain	had	viable	adenomyotic	lesions.	In	other	reports	
concomitant	adenomyosis	was	found	in	36%	[14]	and	25%	[15]	
of	patients	who	underwent	hysterectomy	because	of	UAE	failure.	
Although	 adenomyosis	 is	 not	 regarded	 as	 a	 contraindication	
for	UAE	[16,	17],	results,	especially	long	term	ones,	are	worse	
then	 with	 leiomyomas.	 Approximately	 45%	 of	 women	 with	
adenomyosis	 have	 treatment	 relapse	 after	 2-3	years	 after	UAE	
[18,	19,	20].	Overall,		patients	with	concomitant	adenomyosis	are	
at	greater	risk	for	procedure	failure.
It	 is	obvious	 that	presence	of	fibroids	makes	 identification	
of	adenomyosis	more	difficult.	History,	clinical	examination	and	
imaging	studies	may	be	not	conclusive.	Transvaginal	ultrasound	
has	good	accuracy	in	diagnosis	of	adenomoysis	but	its	specifity	
decreases	significantly	in	the	presence	of	leiomyomas	[21].	It	is	
unclear	if	symptoms	such	as	metrorrhagia	or	dysmenorrhea	are	
related	to	adenomyosis	per	se	or	to	associated	pathologies	[22].	
In	our	population	incidence	of	dysmenorrhoea	was	slightly,	but	
not	significantly,	higher	in	patients	with	adenomyosis.	Data	from	
other	reports	are	contradictory.
In	conclusion,	results	of	our	study	indicate	that	women	with	
leiomyomas	who	delivered	twice	or	more	are	at	greater	risk	for	
concomitant	adenomyosis.	This	determinant	should	be	taken	into	
account	in	patients	planned	for	uterine	artery	embolization.
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